Photo of Bishal Gyawali taken from qcri.queensu.ca
Feb 6, 2024, 15:29
Bishal Gyawali: Chris Booth and I discuss how 25 years of “innovation” in the treatment of metastatic pancreatic cancer has barely budged the survival rates for this still lethal disease
Bishal Gyawali, Associate Professor at Queen’s University, recently shared on X/Twitter:
“Just published in The Lancet Oncology! In this essay, Chris Booth and I discuss how 25 years of ‘innovation’ in the treatment of metastatic pancreatic cancer has barely budged the survival rates for this still lethal disease. Just moving the goalposts doesn’t mean patient outcomes have improved. Patients deserve better.
A little late but I hope GI24 colleagues will appreciate this.”
Source: Bishal Gyawali/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 13:20
Dec 21, 2024, 13:12
Dec 21, 2024, 13:05
Dec 21, 2024, 12:18
Dec 21, 2024, 11:52
Dec 21, 2024, 11:30